Authors
Latest:
Diagnosing Skin Conditions in Diverse Pediatric PatientsTraditional descriptions often cater to lighter skin, necessitating updates to better serve diverse populations.
Latest:
Post-Relapse Treatment of a 50-Year-Old Male Patient with VitiligoContinuing the discussion of a 50-year-old male patient with vitiligo, Anthony Nuara, MD, PhD, addresses the intricacies of treating patients who have relapsed or experienced a loss of efficacy following their initial treatment and highlights how to select 2nd line treatments with greater efficacy.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
Sunscreen Protection for ChildrenProtection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Pointers With Portela: Minimalist Skin Care RoutinesIn this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.
Latest:
Impact of Data on Generalized Pustular PsoriasisAaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Latest:
Addressing the Health Impacts of a Changing ClimateEthan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.
Latest:
Unmasking Botulinum Toxin MythsMisleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Latest:
What Dermatologists Need to Know About the Future of Regenerative AestheticsWhile products like growth factor skincare already have demonstrated benefits, this is only the beginning, according to Prithwiraj Maitra, PhD.
Latest:
Delving Into NP/PA Perspectives on Emerging Atopic Dermatitis Treatment OptionsExplore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.
Latest:
Jay A. Lieberman, MD, FACAAI: Clinical Pearls and Hands-On Educational Opportunities at ACAAI Annual MeetingProgram Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.
Latest:
Key Takeaways on Advanced BCC ManagementPanelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.
Latest:
QUIZ: Sauna-Related Rash - Test Your Medical Insight“Edward” is a 35-year-old Hispanic male presenting with a new rash on the buttocks which has been present for approximately 1 month.
Latest:
Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research DirectionsPanelists discuss how data from head-to-head clinical trials comparing different therapeutic options in atopic dermatitis inform treatment decisions while exploring critical gaps in research that future studies need to address.
Latest:
Take-Home Pearls on the Management of Plaque PsoriasisAlexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.
Latest:
The Skin Smart Campus Initiative: Promoting Skin Health and Public Awareness at GWGeorge Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.
Latest:
How Physicians Can Provide Better Care for Patients with Chronic ConditionsTechnology and care navigators are key to managing this growing population
Latest:
Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic DermatitisRecent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.
Latest:
Do You Have the Right Financial Adviser?Experts detail 5 tips to ask a financial advisor so they can best serve your interests.
Latest:
Pipeline Updates on the Horizon From Arcutis BiotherapeuticsPatrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.
Latest:
Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research DirectionsPanelists discuss how data from head-to-head clinical trials comparing different therapeutic options in atopic dermatitis inform treatment decisions while exploring critical gaps in research that future studies need to address.
Latest:
Exploring the Diagnostics of Urticaria at ACAAISession at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.
Latest:
Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque PsoriasisPapp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.
Latest:
Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis CarePanelists discuss how medical professionals anticipate new IL-17 inhibitor data, particularly from head-to-head trials like BE BOLD. Interest is growing in sonelokimab, an IL-17A/F nanobody (Papp, 2021). Further research is needed on long-term efficacy, safety, and optimal patient selection.
